๐ŸŽ Black Friday: up to 50% off of annual plans
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI ยท Real-Time Price ยท USD
7.05
-0.07 (-0.98%)
Nov 20, 2026, 4:00 PM EST - Market closed

Puma Biotechnology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
231.83228.37230.47235.64228.03253.16
Revenue Growth
9.35%-0.91%-2.19%3.34%-9.92%12.46%
Gross Profit
170.6170.21166.06172.96172.94189.45
Operating Income
26.1437.330.9732.6430.721.29
Net Income
23.8331.1130.2821.590-29.13
Earnings Per Share
0.450.610.620.450.00-0.72
EPS Growth
-38.91%-1.61%37.78%1022625.00%--

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
108.5897.53100.9795.9481.0782.11
Total Debt
4.8728.5574.08111.49114.28116.64
Net Cash (Debt)
103.7168.9826.88-15.55-33.21-34.54
Net Cash Growth
94.45%156.60%----
Net Cash Per Share
1.981.360.55-0.33-0.74-0.85

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
46.0441.838.9227.01-15.8320.65
Capital Expenditures
0.04-0.07-0.06-0.14--
Free Cash Flow
46.0741.7338.8626.87-15.8320.65
Free Cash Flow Growth
7.48%7.38%44.64%--2740.44%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
73.59%74.53%72.06%73.40%75.84%74.84%
Operating Margin
11.27%16.33%13.44%13.85%13.47%0.51%
Pretax Margin
12.12%15.67%10.46%9.62%0.20%-11.38%
Profit Margin
10.28%13.62%13.14%9.16%0.00%-11.51%
FCF Margin
19.87%18.27%16.86%11.40%-6.94%8.16%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.519.644.959.5498021.07-
Forward PE
24.9612.5511.6210.5733.92127.84
P/FCF Ratio
7.917.193.857.67-6.02
PS Ratio
1.571.310.650.870.860.49